CClinicalTrials.gg
CompletedNCT03916159EXPLAINUpdated Nov 8, 2023

Extrauterine Placental Transfusion In Neonatal Resuscitation Of Very Low Birth Weight Infants

An interventional study of Extrauterine placental transfusion (Intervention group) and Delayed cord clamping (Control group) in Very Low Birth Weight Infant, Placental Transfusion and Anemia, sponsored by Universitätsklinikum Köln. Completed at 1 site in Germany. Open to participants aged 24 Weeks and older. Per ClinicalTrials.gov, last updated 2023-11-08.

Sponsored by Universitätsklinikum Köln · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
24 Weeks and older
Sex
All
01

Study summary

To investigate the effect of extrauterine placental transfusion (EPT) compared to delayed cord clamping (DCC) on the mean hematokrit on the first day of life in very low birth weight infants (VLBW) born by caesarian section. The investigators hypothesize that EPT provides higher blood volume during neonatal transition and improves neonatal outcome of VLBW infants.

Read the detailed description

This prospective randomized controlled study will be conducted among 2 groups, all of them are preterm infants with birth weight less than 1500 g ("very low birth weight" (VLBW)) who are delivered by caesarean section, in the first interventional group an extrauterine placental transfusion (EPT) will be done during neonatal resuscitation with respiratory pressure support. There will be a delayed cord clamping (DCC) of at least 30 - 60 seconds in the control group, before starting neonatal resuscitation with respiratory support.

In EPT approach preterm born infants are delivered by caesarean section with the placenta still attached to the infant via the umbilical cord. Then, placental transfusion is performed up to several minutes by holding the placenta \~40-50cm above the babies' heart level while respiratory support by mask continuous-positive-airway-pressure (CPAP) is initiated simultaneously.

Extrauterine placental transfusion may give more blood in babies delivered by cesarean section and may improve perfusion during the fetal-to-neonatal transition with impact on neonatal outcome.

02

Conditions studied

  • Very Low Birth Weight Infant
  • Placental Transfusion
  • Anemia

Keywords

  • extrauterine placental transfusion
  • delayed cord clamping
  • neonatal resuscitation
03

Who can participate

Ages eligible
24 Weeks and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Birth weight \< 1500 gram ("very low birth weight infant")
  • Delivery by caesarean section
  • Gestational age > 23+6 weeks

Exclusion criteria

Exclusion Criteria:

  • Vaginal delivery
  • Fetal or maternal risk (i.e. compromise, emergency c-section)
  • Congenital anomalies and/or major cardiac defects
  • Placental abruption or previa with hemorrhage
  • Placenta accreta or increta
  • Monochorionic multiples (i.e. Di/Mo or Mo/Mo twins)
  • Parents declined study
04

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
60 participants (actual)

Study arms

  • Experimental
    Extrauterine Placental Transfusion EPT

    Intervention group

    Procedure: Extrauterine placental transfusion (Intervention group)

  • Active comparator
    Delayed cord clamping DCC

    Control group

    Procedure: Delayed cord clamping (Control group)

Interventions

  • ProcedureExtrauterine placental transfusion (Intervention group)

    At delivery by caesarean section, the infant is born with the placenta still attached via the umbilical cord and placental transfusion is performed at least 1 minute but not more than 10 minutes by holding the placenta \~40-50cm above the babies' heart level while respiratory support by mask continuous-positive-airway-pressure (CPAP) is initiated simultaneously.

  • ProcedureDelayed cord clamping (Control group)

    At delivery by caesarean section, delayed cord clamping will be performed by having the delivering obstetrician delay clamping of the umbilical cord for at least 30 seconds with initiation of respiratory support by mask CPAP after cord clamping.

05

What researchers measure

Primary outcomes

  1. Hematocrit

    Mean Hematocrit in the first 24 hours of life

    Time frame: 0 - 24 hours of life

Secondary outcomes

  1. Cerebral tissue oxygen saturation

    Transcutaneous measured cerebral tissue oxygen saturation given in percent (%) during neonatal resuscitation

    Time frame: During first hour of life

  2. Mean airway pressure

    Mean airway pressure given in cmH2O during neonatal resuscitation

    Time frame: During first hour of life

  3. Mean tidal volume

    Mean tidal volume given in milliliter (ml) during neonatal resuscitation

    Time frame: During first hour of life

  4. Heart rate

    Heart rate given in beats-per-minute (bpm) during neonatal resuscitation

    Time frame: During first hour of life

  5. Blood oxygen saturation

    Transcutaneous measured blood oxygen saturation given in percent (%) during neonatal resuscitation

    Time frame: During first hour of life

  6. Admission temperature

    Mean temperature at admission

    Time frame: Admission to ward is up to 120 minutes of age

  7. All Grade Intraventricular Hemorrhage (IVH)

    Incidence of any intraventricular hemorrhage (grades 1-4)

    Time frame: Up to 28 days of life

  8. All Grade BPD

    Incidence of Bronchopulmonary Disease (BPD) (all grades)

    Time frame: At the corrected age of 36 weeks

  9. Spontaneous Pneumothorax/Pneumoperitoneum

    Early incidence of spontaneous pneumothorax and/or pneumoperitoneum

    Time frame: During the first 7 days of life

  10. Spontaneous Pneumothorax/Pneumoperitoneum

    Late incidence of spontaneous pneumothorax and/or pneumoperitoneum

    Time frame: Between day 7 and day 28 of life

  11. NEC/SIP with surgery

    Incidence of necrotizing enterocolitis (NEC) and/or spontaneous intestinal perforation (SIP) with need for surgery

    Time frame: During the first 28 days of life

  12. Retinopathy of Prematurity (ROP), higher grades

    Incidence of retinopathy of prematurity with treatment (drugs and/or surgery)

    Time frame: At the corrected age of 40 weeks

  13. Death

    Incidence of death in studied infants

    Time frame: Until corrected age of 40 weeks

  14. Number of participants who received red blood cell (RBC) transfusion

    Amount of RBC Transfusion \[cumulative ml/kg over the first 7 days\] in those participants who received RBC transfusion

    Time frame: During the first 7 days of life

  15. Hyperbilirubinemia

    Peak bilirubin concentration

    Time frame: During the first 14 days of life

  16. Blood Exchange Transfusion

    Incidence of blood exchange transfusion due to critical hyperbilirubinemia of the neonate.

    Time frame: During the first 14 days of life

  17. Intubation and Mechanical Ventilation

    Incidence of intubation and time duration of mechanical ventilation

    Time frame: During the first 72 hours of life

  18. Intubation and Mechanical Ventilation

    Incidence of intubation and time duration of mechanical ventilation

    Time frame: During hospitalization

  19. Neurodevelopmental Outcome

    Bayley Scales of Infant and Toddler Development - Third Edition (Bayley-III) composite score (motor, cognitive, language)

    Time frame: 22-26 month corrected gestational age

06

Study locations

1 site
  • University Hospital of Cologne, Department of pediatrics
    Cologne, Germany
07

References and documents

Publications

  • Kuehne B, Kirchgaessner C, Becker I, Kuckelkorn M, Valter M, Kribs A, Oberthuer A. Mask Continuous Positive Airway Pressure Therapy with Simultaneous Extrauterine Placental Transfusion for Resuscitation of Preterm Infants - A Preliminary Study. Biomed Hub. 2018 Jun 26;3(2):1-10. doi: 10.1159/000488926. eCollection 2018 May-Aug. PubMed 31988958 ↗
  • Kuehne B, Gruttner B, Hellmich M, Hero B, Kribs A, Oberthuer A. Extrauterine Placental Perfusion and Oxygenation in Infants With Very Low Birth Weight: A Randomized Clinical Trial. JAMA Netw Open. 2023 Nov 1;6(11):e2340597. doi: 10.1001/jamanetworkopen.2023.40597. PubMed 37921769 ↗

Individual participant data

Plan to share: No

08

Registry details

Key details

Study ID
NCT03916159
Lead sponsor
Universitätsklinikum Köln
Responsible party
Andre Oberthür (Principal Investigator, Universitätsklinikum Köln) — Principal investigator
First posted
Apr 16, 2019
Start date
May 1, 2019
Primary completion
Dec 5, 2021
Completion
Oct 24, 2023
Last update
Nov 8, 2023

Study contacts

André Oberthuer, MD
principal investigator · University hospital of Cologne, Department of Pediatrics

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion